共 50 条
- [25] The impact of 21-Gene Recurrence Score test and classic clinical-pathologic factors in guiding adjuvant therapy for HER-2 negative, ER-positive, early-stage breast cancer: A retrospective study BREAST JOURNAL, 2020, 26 (05): : 1064 - 1066
- [28] Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer Breast Cancer Research and Treatment, 2018, 168 : 249 - 258
- [30] Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients Journal of Cancer Research and Clinical Oncology, 2023, 149 : 14833 - 14841